Chicago—A broken U.S. drug pricing system is leading to spiraling chemotherapy and other drug costs—and hurting patients—argued Peter B. Bach, MD, the director of the Center for Health Policy and Outcomes at Memorial Sloan Kettering Cancer Center in New York City, during the 2016 annual Hematology/Oncology Pharmacy Association (HOPA) Oncology Pharmacy Practice Management Program.
To fix the system, Dr. Bach argued that drug pricing should be tied to value, and he has created